Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris (original) (raw)

You do not currently have access to this article.

Purchase

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris - 24 Hours access

EUR €58.00

GBP £50.00

USD $62.00

This article is also available for rental through DeepDyve.

Advertisement intended for healthcare professionals